Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models
about
Modelling schizophrenia using human induced pluripotent stem cells.Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune ActivationTranslating the MAM model of psychosis to humansBetter understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse modelsTspyl2 Loss-of-Function Causes Neurodevelopmental Brain and Behavior Abnormalities in Mice.The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and TreatmentBlinded prospective evaluation of computer-based mechanistic schizophrenia disease model for predicting drug responseImpaired cognitive function and altered hippocampal synapse morphology in mice lacking Lrrtm1, a gene associated with schizophreniaSchizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouseEarly Social Isolation Stress and Perinatal NMDA Receptor Antagonist Treatment Induce Changes in the Structure and Neurochemistry of Inhibitory Neurons of the Adult Amygdala and Prefrontal Cortex.Molecular substrates of schizophrenia: homeostatic signaling to connectivityPre-clinical models of neurodevelopmental disorders: focus on the cerebellumMice deficient in transmembrane prostatic acid phosphatase display increased GABAergic transmission and neurological alterations.Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging.Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.Animal models of schizophrenia.Do genes and environment meet to regulate cerebrospinal fluid dynamics? Relevance for schizophrenia.Are NCAM deficient mice an animal model for schizophrenia?Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo.Zic2 hypomorphic mutant mice as a schizophrenia model and ZIC2 mutations identified in schizophrenia patientsHippocampal interneurons are abnormal in schizophrenia.Searching for neuropathology: gliosis in schizophrenia.Effects of background mutations and single nucleotide polymorphisms (SNPs) on the Disc1 L100P behavioral phenotype associated with schizophrenia in mice.14-3-3ζ deficient mice in the BALB/c background display behavioural and anatomical defects associated with neurodevelopmental disordersIn vivo imaging of neuroinflammation in schizophreniaHippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis.Linking neurodevelopmental and synaptic theories of mental illness through DISC1Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders.Brain in flames - animal models of psychosis: utility and limitationsSubchronic phencyclidine treatment in adult mice increases GABAergic transmission and LTP threshold in the hippocampus.Risperidone and NAP protect cognition and normalize gene expression in a schizophrenia mouse modelIncreased co-expression of genes harboring the damaging de novo mutations in Chinese schizophrenic patients during prenatal development.The proteome of schizophrenia.Cognitive and motivational deficits together with prefrontal oxidative stress in a mouse model for neuropsychiatric illness.Global signaling effects of a schizophrenia-associated missense mutation in neuregulin 1: an exploratory study using whole genome and novel kinome approaches.Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells.Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia.Evaluating Synthetic Activation and Repression of Neuropsychiatric-Related Genes in hiPSC-Derived NPCs, Neurons, and Astrocytes.Hippocampal oscillations in the rodent model of schizophrenia induced by amygdala GABA receptor blockade.
P2860
Q24633007-77C995C3-E602-4862-820E-0EC3075221B0Q26775092-4F5DCE29-AE20-470F-B4C7-6DC9675C0525Q26860217-033FE4AF-C05F-42D8-90D2-CBCB2C98D54CQ26866254-3E46DC86-AC8E-4355-8F31-542ED541C946Q27317408-FEC291EC-E509-4780-9F4C-AD74AE908F1DQ28081659-B6CAD7A7-6C23-4233-A0BD-86B4E192B209Q28484377-48E37C5F-0DCC-4484-9A3C-66F62EBC549BQ28511664-0220BC2E-EDC9-4701-8EA4-B3FC36CE4B0DQ28727394-0430FA7D-89CC-4A25-8133-BE6CDCAC868EQ30357412-8BC7B6CE-22A3-4D07-A485-947F1A23A790Q30383611-A65FE47A-C81C-45B6-91E4-11CA17CB9483Q30436913-5F60BFF2-C6E5-4E45-A0CF-DA5BA506D4D6Q30438217-FDF0073A-8CE6-4AC9-AC44-E72D0CC9C75CQ30440091-304F6CAE-A2DE-4356-9CBA-056206F91E97Q30454958-486C543D-A649-489E-A0E3-8D80E187C35DQ30462828-B4FC7CE4-D22D-4F48-88D6-3552C0030E4CQ30464730-3DF7EE7A-6CDA-464C-B439-745111215A6AQ30465582-50B6D7AA-F7F1-4054-B33B-0AD184379494Q30468813-80E25566-13D9-481A-9A21-F124CE4BCF5CQ30472033-79A62928-D9F1-47E4-A2E0-23D820098CE3Q30503608-EB957711-EA8D-4B21-A2E0-88ECD7620971Q30537360-61C96D1C-5215-4CF6-B66C-953EA14610B5Q30615734-C0BE0BCC-2D01-4C2D-AA02-AE66AB5E2764Q30658834-96978DD0-06B3-4A74-93FA-65D96CC159F6Q30966978-83195505-BC3C-4690-A30A-71F8A7075263Q33885557-8EA192C8-69D5-434F-B669-989D5ADD03D6Q34233683-4716C680-06B4-493A-B6AD-A529061BA702Q34423863-93FA2DCF-565F-4E1F-84E8-5A9055F619C5Q34689823-CC415C7D-6572-4B4B-A40A-D26C5D809D4EQ35683865-DCF50565-F032-47CF-8992-F2A4AF82E495Q36096029-386CC949-16C5-4CD9-A2DE-039E14769BC7Q36265934-1C89B0CF-E835-4046-BDE2-FF9B120148C2Q36371011-3E038499-2543-4286-A1C5-3C5441184A9CQ36848272-A2645F32-DD04-4542-B1D6-2BA0117F54C2Q37049425-3E0E49B6-C284-455A-A075-DAD0ED7DB7EFQ37722635-777A9E1A-00D8-40C1-ABF9-089EF9EF03C3Q38170728-DAAC29A9-500E-4CBE-9348-05B098BE2383Q38857414-27A6D403-2BF0-4614-8AF4-2647A4FA2E31Q41327318-2D25748D-2829-4F3F-9B35-3CABAD22DEB7Q42106519-40EEC8C0-139A-4DF9-BAE9-6BFC501A98F5
P2860
Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Review of pathological hallmar ...... patients and nongenetic models
@ast
Review of pathological hallmar ...... patients and nongenetic models
@en
type
label
Review of pathological hallmar ...... patients and nongenetic models
@ast
Review of pathological hallmar ...... patients and nongenetic models
@en
prefLabel
Review of pathological hallmar ...... patients and nongenetic models
@ast
Review of pathological hallmar ...... patients and nongenetic models
@en
P2093
P2860
P356
P1476
Review of pathological hallmar ...... patients and nongenetic models
@en
P2093
Akira Sawa
Hanna Jaaro-Peled
Mikhail V Pletnikov
Yavuz Ayhan
P2860
P304
P356
10.1093/SCHBUL/SBP133
P407
P577
2009-11-10T00:00:00Z